NCT02044965View on ClinicalTrials.gov

Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Urinary Tract Infection
Interventions
OTHER

Antibiotic

2 mg/kg per day via oral ingestion.

DRUG

Probiotic

2 capsules; 5 billion total organisms of L. rhamnosus GR-1 and L. reuteri RC-14 per capsule

Trial Locations (1)

N6A 4G5

RECRUITING

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
collaborator

Canadian Urological Association

INDUSTRY

lead

London Health Sciences Centre

OTHER